Acura Pharma (ACUR) Misses Q2 EPS by 3c

Acura Pharma (NASDAQ: ACUR) reported Q2 EPS of ($0.05), $0.03 worse than the analyst estimate of ($0.02).

For earnings history and earnings-related data on Acura Pharma (ACUR) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• RMX Industries signs GPU purchase order with Technologent
• BofA says investors are increasingly worried about an AI boom-bust cycle